ClassID:

21256

A61K45/06 - page 22 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  -  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Recent Application in this class:
#6301
20240016899
2024-01-18

ORAL OCTREOTIDE FOR THE TREATMENT OF DISEASE

#6302
20240016890
2024-01-18

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CANCER

#6303
20240016885
2024-01-18

CYCLOSPORINE FORMULATIONS FOR USE IN THE PREVENTION OR TREATMENT OF PULMONARY CHRONIC GRAFT REJECTION

#6304
20240016869
2024-01-18

Method of precision dosing

#6305
20240016868
2024-01-18

Color Coded Cannabis Variety Pack and Directive of Use

#6306
20240016852
2024-01-18

Application of Retinal Pigment Epithelial Cells as Corneal Endothelial Substitute

#6307
20240016843
2024-01-18

APPLICATION OF NKG2D CAR-IMMUNOCYTE IN TREATMENT OF ANTI-AGING AND AGE-RELATED DISEASES

#6308
20240016840
2024-01-18

METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINATION WITH KINASE INHIBITORS

#6309
20240016828
2024-01-18

INHIBITION OF NGLY1 FOR THE TREATMENT OF CANCER

#6310
20240016821
2024-01-18

DRINK PRODUCT AND USE THEREOF

#6311
20240016820
2024-01-18

Lipid Disulfide Prodrugs and Uses Related Thereto

#6312
20240016817
2024-01-18

Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders

#6313
20240016816
2024-01-18

COMBINATION THERAPY

#6314
20240016814
2024-01-18

METHOD OF TREATING HYPERTENSION

#6315
20240016809
2024-01-18

USE OF PPAR-DELTA AGONISTS IN THE TREATMENT OF DISEASE

#6316
20240016808
2024-01-18

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#6317
20240016800
2024-01-18

METHODS OF TREATING NEUROFIBROMATOSIS WITH PERILLYL ALCOHOL

#6318
20240016799
2024-01-18

ANTI-INFLAMMATORY, ANTI-CANCER, AND ANTI-ANGIOGENIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEREOF

#6319
20240016796
2024-01-18

Pharmaceutical Composition Comprising Mineralocorticoid Receptor Antagonist and Use Thereof

#6320
20240016785
2024-01-18

CLOPIDOGREL FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

#6321
20240016781
2024-01-18

TREATMENT OF KRAS MUTANT CANCERS

#6322
20240016777
2024-01-18

COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTIONS

#6323
20240016764
2024-01-18

HEXYLAMINE SALTS AND METHODS OF USING HEXYLAMINE

#6324
20240016760
2024-01-18

Multivitamin

#6325
20240016754
2024-01-18

PHARMACEUTICAL COMPOSITION CONTAINING TAXANE NANOAGGREGATES AND USE THEREOF

#6326
20240016746
2024-01-18

Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement

#6327
20240016733
2024-01-18

Oral Product Comprising an Antiviral Active Ingredient

#6328
20240012011
2024-01-11

METHODS AND ASSAYS FOR SECRETOME ACTIVITY ANALYSIS

#6329
20240011991
2024-01-11

COMPOSITIONS AND METHODS FOR PREDICTING RISK OF MODERATE TO SEVERE COVID-19 DISEASE

#6330
20240011036
2024-01-11

PREVENTION OR TREATMENT OF WASTING SYNDROME

#6331
20240011008
2024-01-11

PH20 polypeptide variants, formulations and uses thereof

#6332
20240010976
2024-01-11

METHODS AND COMPOSITIONS FOR STIMULATING GAMMA DELTA T CELLS

#6333
20240010719
2024-01-11

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

#6334
20240010697
2024-01-11

MODIFIED INTERLEUKIN 2 (IL-2) POLYPEPTIDES, AND METHODS OF MAKING AND USING THE SAME

#6335
20240010678
2024-01-11

METHOD OF TREATMENT OF IRRITABLE BOWEL SYNDROME

#6336
20240010655
2024-01-11

DIHYDROIMIDAZO PYRIMIDO PYRIMIDINONE COMPOUND

#6337
20240010641
2024-01-11

N-Linked Glycosylation Inhibitors and Methods of Using Same

#6338
20240010634
2024-01-11

PYRIMIDINYL SULFONAMIDES AS INHIBITORS OF ACK1/TNK2 TYROSINE KINASE

#6339
20240009434
2024-01-11

APPLYING THERAPEUTIC AGENTS FOR GENITAL AND ANAL PRE-CANCER TREATMENT, INCLUDING CERVICAL INTRAEPITHELIAL NEOPLASIA

#6340
20240009323
2024-01-11

METHODS OF TREATING COLON CANCER USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY

#6341
20240009321
2024-01-11

IMMUNOGENIC NANOVESICLES FOR CANCER IMMUNOTHERAPY

#6342
20240009305
2024-01-11

METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS

#6343
20240009284
2024-01-11

METHOD AND COMPOSITION FOR TREATING ARGINASE 1 DEFICIENCY

#6344
20240009278
2024-01-11

METHODS OF TREATING INFERTILITY

#6345
20240009277
2024-01-11

POLYPEPTIDES FOR USE IN THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES

#6346
20240009274
2024-01-11

Use of NRG-1Beta1 for Detection and/or Treatment of Multiple Sclerosis

#6347
20240009272
2024-01-11

METHODS, SYSTEMS, AND COMPOSITIONS FOR LEGUME-BASED PRODUCTION OF THERAPEUTIC PROTEINS AND THERAPEUTIC MEDICAL MATERIALS

#6348
20240009271
2024-01-11

METHODS OF TREATING METASTATIC CANCERS USING AXL DECOY RECEPTORS

#6349
20240009270
2024-01-11

COVERSIN FOR THE TREATMENT OF AUTOIMMUNE BLISTERING DISEASES

#6350
20240009241
2024-01-11

ENGINEERED T CELL RECEPTORS TARGETING EGFR ANTIGENS AND METHODS OF USE

#6351
20240009240
2024-01-11

ENGINEERED T CELL RECEPTORS TARGETING EGFR ANTIGENS AND METHODS OF USE

#6352
20240009228
2024-01-11

PEGYLATED RAPAMYCIN COMPOUND AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#6353
20240009223
2024-01-11

6-THIO-2'-DEOXYGUANOSINE (6-THIO-DG) RESULTS IN TELOMERASE DEPENDENT TELOMERE DYSFUNCTION AND CELL DEATH IN VARIOUS MODELS OF THERAPY-RESISTANT CANCER CELLS

#6354
20240009218
2024-01-11

COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND QUERCETIN FOR USE IN CARTILAGE DEGENERATION

#6355
20240009214
2024-01-11

Method of Treating Viral Infection

#6356
20240009212
2024-01-11

PHOSPHAPLATIN COMPOUNDS AS THERAPEUTIC AGENTS SELECTIVELY TARGETING HIGHLY GLYCOLYTIC TUMOR CELLS AND METHODS THEREOF

#6357
20240009211
2024-01-11

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF LUNG CANCER COMPRISING CANNABIDIOL AND ANTICANCER AGENT AS ACTIVE INGREDIENTS, AND USE THEREOF

#6358
20240009195
2024-01-11

NOVEL USES

#6359
20240009190
2024-01-11

COMBINATION CANCER THERAPY USING CHK INHIBITOR

#6360
20240009187
2024-01-11

Methods of Treating Ischemic Disease by Administering an ATR Kinase Inhibitor

#6361
20240009173
2024-01-11

Use of 5-HT3-Targeting Drugs for Treatment of Acute Kidney Injury

#6362
20240009170
2024-01-11

INHIBITION OF GLYCOGEN SYNTHASE KINASE-3 (GSK-3)

#6363
20240009166
2024-01-11

USE OF ZANAMIVIR IN PREPARATION OF DRUG FOR TREATING OR PREVENTING PREECLAMPSIA

#6364
20240009161
2024-01-11

THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES

#6365
20240009154
2024-01-11

METHODS AND COMPOSITIONS FOR TREATING CYTOKINE RELEASE SYNDROME

#6366
20240009144
2024-01-11

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING TISSUE CALCIFICATION

#6367
20240009132
2024-01-11

CANNABINOIDS IN THE TREATMENT OF AUTISM SPECTRUM DISORDER

#6368
20240009129
2024-01-11

PACKAGING FOR RAPIDLY INFUSING COMPOSITION

#6369
20240009124
2024-01-11

Ophthalmic Suspension Base having a Micro-fluidized Positively Charged Nanoparticle

#6370
20240003901
2024-01-04

ASSAYS FOR FABRY DISEASE TREATMENT

#6371
20240002935
2024-01-04

GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS

#6372
20240002826
2024-01-04

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

#6373
20240002825
2024-01-04

PH20 polypeptide variants, formulations and uses thereof

#6374
20240002515
2024-01-04

METHODS AND ANTIBODIES FOR MODULATION OF IMMUNORESPONSE

#6375
20240002501
2024-01-04

ANTI-L1-CAM ANTIBODIES AND USES THEREOF

#6376
20240002492
2024-01-04

METHODS AND TREATMENT INVOLVING EXCESS FREE LIGHT

#6377
20240002490
2024-01-04

USE OF ANTI-PRO/LATENT MYOSTATIN ANTIBODY FOR TREATING SPINAL MUSCULAR ATROPHY

#6378
20240002478
2024-01-04

Methods and composition for neutralization of influenza

#6379
20240002441
2024-01-04

PEPTIDES AND USES THEREOF IN MODULATION OF AMYLOID-BETA PROTEIN DEGRADING PROTEASES

#6380
20240002440
2024-01-04

AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS

#6381
20240002429
2024-01-04

PRODRUG OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3ß-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER

#6382
20240002401
2024-01-04

IMIDAZOTHIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#6383
20240002395
2024-01-04

COMPOUNDS AND THEIR USE FOR TREATING NEUROPATHIC PAIN

#6384
20240002388
2024-01-04

PYRIMIDINONE COMPOUNDS AND USES THEREOF

#6385
20240002384
2024-01-04

3,4-DIHYDRO-2,7-NAPHTHYRIDINE-1,6(2H,7H)-DIONES AS MEK INHIBITORS

#6386
20240002363
2024-01-04

HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

#6387
20240002360
2024-01-04

BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR

#6388
20240002354
2024-01-04

ANTIDIABETIC COMPOUNDS AND COMPOSITIONS

#6389
20240002347
2024-01-04

Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death

#6390
20240001259
2024-01-04

Dephosphorylation-controlled extraction of phosphorylatable psychoactive alkaloids

#6391
20240001156
2024-01-04

APPARATUS, METHOD, AND USE FOR ULTRASOUND MEDIATED MICROBUBBLE DELIVERY OF PHARMACEUTICAL COMPOSITIONS

#6392
20240001155
2024-01-04

REVERSAL OF CELLULAR SENESCENCE BY TREATMENT WITH LOW FREQUENCY ULTRASOUND

#6393
20240001094
2024-01-04

PREPARATION COMPRISING EXANATIDE FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT

#6394
20240000954
2024-01-04

COMPLEX OF BETA-GLUCAN AND NUCLEIC ACID HAVING CONTROLLED PARTICLE SIZE

#6395
20240000952
2024-01-04

METHODS AND KITS FOR IDENTIFYING SUBJECTS RESPONSIVE TO ARGININE DEPRIVATION THERAPY

#6396
20240000949
2024-01-04

Nucleic Acid-Derivatized Therapeutics

#6397
20240000938
2024-01-04

ADOPTIVE CELL THERAPY FOR TREATMENT OF CANCER ASSOCIATED WITH LOSS OF HETEROZYGOSITY

#6398
20240000931
2024-01-04

METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS BY ADMINISTERING AN ANTI-IL4R-ALPHA ANTIBODY

#6399
20240000928
2024-01-04

APPROACH FOR TREATMENT OF CANCER VIA IMMUNOMODULATION BY USING TALABOSTAT

#6400
20240000911
2024-01-04

PEPTIDE VACCINES

#6401
20240000903
2024-01-04

METHOD AND DRUG FOR INCREASING BDNF LEVEL

#6402
20240000895
2024-01-04

Treatment Of Females Having BRCA1/2 Mutations With Human Chorionic Gonadotropin To Reduce The Risk Of Developing Breast Cancer

#6403
20240000894
2024-01-04

Treatment of post-bariatric hypoglycemia with exendin (9-39)

#6404
20240000893
2024-01-04

Medical use of interferon-lambda for the treatment of fibrosis

#6405
20240000892
2024-01-04

Agents and Methods for Increasing Liver Immune Response

#6406
20240000889
2024-01-04

METHOD FOR TREATING OR PREVENTING IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)

#6407
20240000888
2024-01-04

GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF

#6408
20240000883
2024-01-04

METHOD OF SENSITIZING CANCERS TO IMMUNOTHERAPY USING IMMUNOMODULATORY AGENTS

#6409
20240000882
2024-01-04

COMPOSITIONS AND METHODS FOR BODY CONTOURING AND SURGICAL PROCEDURES

#6410
20240000880
2024-01-04

A PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LUNG INJURY, A PREPARATION METHOD THEREFOR AND A USE THEREOF

#6411
20240000858
2024-01-04

HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

#6412
20240000846
2024-01-04

COMPOSITIONS AND METHODS FOR TREATING HEMATOPOIETIC MALIGNANCY

#6413
20240000834
2024-01-04

RAS MUTANT EPITOPE PEPTIDE AND T CELL RECEPTOR RECOGNIZING RAS MUTANT

#6414
20240000825
2024-01-04

USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION

#6415
20240000823
2024-01-04

COMPOSITIONS AND METHODS OF TREATING FANCONI ANEMIA

#6416
20240000816
2024-01-04

Therapeutic treatment of breast cancer based on c-MAF status

#6417
20240000809
2024-01-04

IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

#6418
20240000808
2024-01-04

IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF ALZHEIMER'S DISEASE

#6419
20240000798
2024-01-04

Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols

#6420
20240000795
2024-01-04

METHODS AND COMPOSITIONS RELATING TO CONTROLLING PSYCHEDELIC EFFECTS WITH SEROTONIN RECEPTOR MODULATORS

#6421
20240000792
2024-01-04

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#6422
20240000790
2024-01-04

THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE

#6423
20240000783
2024-01-04

COMBINATION THERAPY

#6424
20240000774
2024-01-04

USE OF FATTY ACID OXIDATION INHIBITORS AS ANTIMICROBIALS

#6425
20240000768
2024-01-04

METHOD FOR THE TREATMENT OF DISEASES ASSOCIATED WITH SULFATASE DEFICIENCIES

#6426
20240000760
2024-01-04

Roflumilast formulations with an improved pharmacokinetic profile

#6427
20240000743
2024-01-04

Method of preventing and treating chemotherapy-induced alopecia

#6428
20240000733
2024-01-04

COMPOSITION AND METHOD FOR TREATMENT OF DIABETES

#6429
20240000731
2024-01-04

Non-linear dosing of mirdametinib

#6430
20240000730
2024-01-04

ANTIHISTAMINE SEMI-SOLID CHEWABLE GEL COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF

#6431
20240000704
2024-01-04

METHODS OF USING UMBILICAL CORD PRODUCTS FOR TREATMENT OF OCULAR SURFACE DISORDERS

#6432
20240000703
2024-01-04

METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE

#6433
20230416834
2023-12-28

METHODS AND COMPOSITIONS FOR DETECTING RISK OF CANCER RELAPSE

#6434
20230416750
2023-12-28

CATALYTIC SEQUENCE BASED METHODS OF TREATING OR PREVENTING BACTERIAL INFECTIONS

#6435
20230416721
2023-12-28

COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS)

#6436
20230416399
2023-12-28

METHODS FOR TREATING CANCER WITH ANTI-GD2/GD3 ANTIBODIES

#6437
20230416396
2023-12-28

MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, AND USES THEREOF

#6438
20230416385
2023-12-28

Bispecific antibody binding BCMA and CD3

#6439
20230416384
2023-12-28

METHODS OF TREATING SEVERE INSULIN RESISTANCE BY INTERFERING WITH GLUCAGON RECEPTOR SIGNALING

#6440
20230416381
2023-12-28

METHODS FOR TREATING OR PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME

#6441
20230416368
2023-12-28

Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein 3 (TIM-3)

#6442
20230416362
2023-12-28

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

#6443
20230416361
2023-12-28

ENGINEERED CD200R ANTIBODIES AND USES THEREOF

#6444
20230416346
2023-12-28

C-TERMINAL SPARC FRAGMENTS FOR TREATING CANCER

#6445
20230416344
2023-12-28

METHODS FOR TREATING A COMPLEMENT MEDIATED DISORDER CAUSED BY VIRUSES

#6446
20230416335
2023-12-28

T cell receptors

#6447
20230416306
2023-12-28

WAFER LEVEL CHIP SCALE PACKAGE WITH RHOMBUS SHAPE

#6448
20230416294
2023-12-28

DECITABINE ANALOGS FOR IMMUNOLOGICAL AND ONCOLOGICAL THERAPY

#6449
20230416275
2023-12-28

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#6450
20230416261
2023-12-28

ETHANEDIAMINE-HETEROCYCLE DERIVATIVES AS INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASES

#6451
20230416247
2023-12-28

DRUG-LIKE MOLECULES AND METHODS FOR THE THERAPEUTIC TARGETING OF MICRORNA-21

#6452
20230416242
2023-12-28

DOUBLE DEGRADERS AND USES THEREOF

#6453
20230416241
2023-12-28

Broad Spectrum Antiviral Compositions and Methods

#6454
20230416227
2023-12-28

PLASMA KALLIKREIN INHIBITORS

#6455
20230416206
2023-12-28

COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING DISEASES

#6456
20230416200
2023-12-28

Quaternary tryptamines and their therapeutic uses

#6457
20230416195
2023-12-28

Treatment of cataplexy

#6458
20230414794
2023-12-28

PSMA INHIBITOR, COMPOUND AND APPLICATION

#6459
20230414786
2023-12-28

PERFUSION-GUIDED GENE THERAPY FOR IMPROVING CANCER TREATMENT

#6460
20230414774
2023-12-28

ANTI-CLDN18.2 ANTIBODY, DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#6461
20230414773
2023-12-28

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

#6462
20230414762
2023-12-28

PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED PRODRUG FOR SELECTIVE KILLING OF CELLS EXPRESSING PSMA

#6463
20230414735
2023-12-28

NEOANTIGENS AND METHODS OF THEIR USE

#6464
20230414719
2023-12-28

METHODS OF USING PLATELET FACTOR 4 AS AN ANTIMICROBIAL AGENT

#6465
20230414717
2023-12-28

MODIFIED FIBROBLAST GROWTH FACTOR 21 (FGF-21) FOR USE IN METHODS FOR TREATING NONALCOHOLIC STEATOHEPATITIS (NASH)

#6466
20230414714
2023-12-28

COMPOSITIONS, METHODS AND KITS FOR TREATING COMPLEMENT RELATED DISORDERS

#6467
20230414704
2023-12-28

Compositions Containing a Pharmacophore with Selectivity to Diseased Tissue and Methods of Making Same

#6468
20230414703
2023-12-28

PD-1 Peptide Inhibitors

#6469
20230414700
2023-12-28

TG2 INHIBITORS FOR IMPROVING MUCOCILIARY CLEARANCE IN RESPIRATORY DISEASES

#6470
20230414693
2023-12-28

Dual acting polymers in an osmotic film for topical application to treat inflammatory diseases and cytokine release syndrome

#6471
20230414692
2023-12-28

ETHANOLIC EXTRACT OF SEEDS OF SOLANUM MELONGENA, METHOD FOR OBTAINING IT, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE THEREOF AS AN ANTITUMOUR AGENT

#6472
20230414687
2023-12-28

COMBINED FUNGAL COMPOSITION FOR MODULATING AN INFLAMMATORY RESPONSE

#6473
20230414677
2023-12-28

Allograft tolerance without the need for systemic immune suppression

#6474
20230414664
2023-12-28

GENETIC MODIFICATIONS FOR XENOTRANSPLANTATION

#6475
20230414660
2023-12-28

PD-1 DECOY VARIANTS FOR IMMUNOTHERAPY

#6476
20230414655
2023-12-28

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VENOM RELATED POISONING

#6477
20230414653
2023-12-28

TOPICAL CHLORINE DIOXIDE TREATMENT FOR MAMMALIAN TEATS

#6478
20230414636
2023-12-28

USE OF GABAA MODULATORS FOR TREATMENT OF RESPIRATORY CONDITIONS

#6479
20230414635
2023-12-28

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

#6480
20230414624
2023-12-28

METHODS OF TREATING NEUROLOGICAL VENTILATORY INSUFFICIENCY

#6481
20230414614
2023-12-28

Methods of treating disorders using CSF1R inhibitors

#6482
20230414611
2023-12-28

REFINED USES OF GABA A RECEPTOR MODULATORS IN TREATMENT OF FRAGILE X SYNDROME

#6483
20230414608
2023-12-28

USE OF ATR AND CHK1 INHIBITOR COMPOUNDS

#6484
20230414594
2023-12-28

COMPOSITION, USES, AND METHODS OF TREATING SPINAL DISC DEGENERATION THROUGH SONIC HEDGEHOG SIGNALING PATHWAY

#6485
20230414590
2023-12-28

THERAPEUTIC SMALL MOLECULES FOR TREATMENT OF PULMONARY HYPERTENSION

#6486
20230414589
2023-12-28

Inhibition of crystal growth of roflumilast

#6487
20230414579
2023-12-28

PHARMACEUTICALS FOR COVID19 TREATMENT

#6488
20230414576
2023-12-28

LONG-ACTING SPIRO-ISOXAZOLINE ANTIPARASITIC COMPOSITIONS

#6489
20230414573
2023-12-28

SYNERGISTIC OPHTHALMOLOGICAL COMPOSITION IN A LOW-CONCENTRATION DOSE THAT IS EFFECTIVE IN THE PREVENTION, CONTROL AND ERADICATION OF PRESBYOPIA

#6490
20230414565
2023-12-28

COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL MALIGNANCIES

#6491
20230414558
2023-12-28

PLECTRANTHUS AMBOINICUS EXTRACT FOR USE IN ALLEVIATION OF RADIATION-INDUCED SKIN DISORDERS

#6492
20230414557
2023-12-28

NEW THERAPY CONCEPT FOR THE TREATMENT OF CORONA INFECTIONS, ESPECIALLY COVID-19 INFECTIONS

#6493
20230414555
2023-12-28

USE OF DIHYDROMYRICETIN AS EPIGENETIC ACTIVE INGREDIENT FOR COSMETIC OR DERMATOLOGICAL SKIN CARE

#6494
20230414546
2023-12-28

Combined Therapy Against Cancer

#6495
20230414544
2023-12-28

HICA FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF A DISEASE OR CONDITION INVOLVING DEGRADATION OF CARTILAGE AND/OR DISRUPTION OF CARTILAGE HOMEOSTASIS AND/OR INTEGRITY

#6496
20230414539
2023-12-28

Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent and statin

#6497
20230414531
2023-12-28

System and Method for Controlling the Humidity and Pressure in a Luminaire

#6498
20230414527
2023-12-28

FIBRIN PARTICLES AND METHODS OF MAKING THE SAME

#6499
20230414521
2023-12-28

SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME

#6500
20230414515
2023-12-28

ACETIC ACID AS PROCESSING AID IN SPRAY DRYING FOR BASIC DRUGS

#6501
20230414505
2023-12-28

EMULSIONS FOR TREATING MUCOUS MEMBRANE INFECTIONS

#6502
20230414502
2023-12-28

Method for Preparing an Aqueous Nanocrystalline Suspension Containing Nanocrystals of Pharmaceutically Active Ingredient and a Combination of Stabilizers, Aqueous Nanocrystalline Suspension and Methods of Use Thereof

#6503
20230414495
2023-12-28

PUNCTAL PLUGS CONTAINING MICELLE-ENCAPSULATED OPHTHALMIC PHARMACEUTICALS AND METHODS FOR MAKING THEREOF

#6504
20230414494
2023-12-28

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA

#6505
20230414493
2023-12-28

Vasoconstriction compositions and methods of use

#6506
20230414491
2023-12-28

KITS, SYSTEMS, AND METHODS FOR REDUCING SURGICAL SITE INFECTIONS

#6507
20230407397
2023-12-21

METHODS FOR IDENTIFYING DRIVERS OF IMMUNE RESPONSES USING MOLECULAR EXPRESSION SIGNATURES OF IMMUNOMODULATING AGENTS

#6508
20230406949
2023-12-21

COMBINATORIAL IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR PANCREATIC DUCTAL ADENOCARCINOMA TREATMENT

#6509
20230406947
2023-12-21

LIGHT INHIBITORS FOR SCLERODERMA AND SKIN FIBROTIC DISEASE TREATMENT

#6510
20230406946
2023-12-21

ANTIBODIES AND METHODS OF USE THEREOF

#6511
20230406944
2023-12-21

IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells

#6512
20230406941
2023-12-21

Anti-AXL Antagonistic Antibodies

#6513
20230406940
2023-12-21

ANTI-cMET ANTIBODY

#6514
20230406928
2023-12-21

METHODS OF TREATING NEUROMYELITIS OPTICA SPECTRUM DISORDER

#6515
20230406918
2023-12-21

METHOD OF TREATMENT OF A TUMOR WITH IL-8 ANTIBODY

#6516
20230406912
2023-12-21

HUMANISED ANTIBODIES AGAINST PATHOGENIC FUNGI

#6517
20230406911
2023-12-21

COMPOSITIONS AND METHODS FOR PREVENTING, INHIBITING, DISRUPTING, OR TREATING A POLYMICROBIAL BIOFILM

#6518
20230406907
2023-12-21

Neutralizing Antibodies that Bind the SARS-COV-2 S Protein

#6519
20230406860
2023-12-21

HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE

#6520
20230406857
2023-12-21

Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders

#6521
20230406824
2023-12-21

TRYPTAMINE DERIVATIVES AND THEIR THERAPEUTIC USES

#6522
20230406823
2023-12-21

4-pivaloyloxy-n-methyltryptammonium chloride

#6523
20230406813
2023-12-21

P62-ZZ CHEMICAL INHIBITOR

#6524
20230405292
2023-12-21

Drug Delivery Devices with Drug-Permeable Component and Methods

#6525
20230405191
2023-12-21

ANTIMICROBIAL CATHETERS

#6526
20230405152
2023-12-21

METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES

#6527
20230405129
2023-12-21

PROINFLAMMATORY PRODRUGS

#6528
20230405126
2023-12-21

FORMULATIONS AND USES THEREOF

#6529
20230405125
2023-12-21

TREATMENT OF RECURRENT GIOBLASTOMA WITH PERILLYL ALCOHOL

#6530
20230405121
2023-12-21

ENGINEERED IPSC AND IMMUNE EFFECTOR CELLS FOR HETEROGENOUS TUMOR CONTROL

#6531
20230405118
2023-12-21

STAT-ACTIVATED MACROPHAGES, COMPOSITIONS, AND USES THEREOF

#6532
20230405102
2023-12-21

NEOANTIGENS AND METHODS OF THEIR USE

#6533
20230405099
2023-12-21

Method and compositions for inhibiting or preventing adverse effects of oral antibiotics

#6534
20230405098
2023-12-21

TYPE E BOTULINUM TOXIN TO TREAT BOTULISM

#6535
20230405090
2023-12-21

ANTIVIRAL AGENTS

#6536
20230405079
2023-12-21

Lisinopril formulations

#6537
20230405063
2023-12-21

USE OF PROBIOTIC COMPONENT AND PHARMACEUTICAL COMPOSITION CONTAINING PROBIOTIC COMPONENT

#6538
20230405060
2023-12-21

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES

#6539
20230405059
2023-12-21

A MYCOBACTERIUM FOR USE IN CANCER THERAPY

#6540
20230405058
2023-12-21

EXTRACELLULAR VESICLES FROM PREVOTELLA

#6541
20230405050
2023-12-21

COMPOSITION FOR TREATING INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-TREATED STEM CELLS

#6542
20230405030
2023-12-21

TOPICAL COMPOSITIONS INCORPORATING SILICA FIBERS

#6543
20230405029
2023-12-21

Bortezomib compositions

#6544
20230405027
2023-12-21

INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS

#6545
20230405026
2023-12-21

A Method of Treating Depression by Immune Modulation

#6546
20230405025
2023-12-21

CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES

#6547
20230405019
2023-12-21

ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT

#6548
20230405018
2023-12-21

FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS

#6549
20230405013
2023-12-21

Methods of treating B-cell proliferative disorder

#6550
20230405011
2023-12-21

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#6551
20230404999
2023-12-21

COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID

#6552
20230404985
2023-12-21

METHODS OF TREATING TUMORS AND CANCERS HAVING DYSREGULATED WNT SIGNALING PATHWAYS

#6553
20230404979
2023-12-21

ALPHA-2 ADRENERGIC RECEPTOR AGONISTS TO REDUCE MORTALITY AND IMPROVE OUTCOMES IN VIRAL RESPIRATORY SYNDROMES

#6554
20230404977
2023-12-21

MODULATORS OF GTPASES AND THEIR USE

#6555
20230404974
2023-12-21

Transmucosal dephosphorylated psychoactive alkaloid composition and preparation thereof

#6556
20230404967
2023-12-21

METHODS TO SENSITIZE CANCER CELLS TO IMMUNE ATTACK USING ATRACTYLENOLIDE I

#6557
20230404960
2023-12-21

Disorders implicating PUFA oxidation

#6558
20230404949
2023-12-21

METHOD OF TREATING OR PREVENTING NEURODEGENERATION

#6559
20230404941
2023-12-21

Use of cannabidiol in treatment of pulmonary hypertension

#6560
20230404917
2023-12-21

RUXOLITINIB OR DEUTERATED RUXOLITINIB COMPOSITION AND USES THEREOF

#6561
20230404912
2023-12-21

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA

#6562
20230399413
2023-12-14

ANTIBODIES AND METHODS OF USE THEREOF

#6563
20230399404
2023-12-14

SUSTAINED ANTIBODY AND IMMUNOTHERAPEUTIC DELIVERY TO CERVICAL LYMPH NODES

#6564
20230399382
2023-12-14

Polyomavirus neutralizing antibodies

#6565
20230399312
2023-12-14

SUBSTITUTED PYRIMIDINES AND METHODS OF USE

#6566
20230399308
2023-12-14

2,6-DISUBSTITUTED PYRIDINE DERIVATIVE

#6567
20230399292
2023-12-14

Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms

#6568
20230399291
2023-12-14

Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms

#6569
20230399290
2023-12-14

Anesthetic compounds and methods of making and using same to treat or prevent pain symptoms

#6570
20230398351
2023-12-14

METHODS FOR TREATING HORMONAL DISORDERS

#6571
20230398241
2023-12-14

RADIOLABELED ETHER DENDRIMER CONJUGATES FOR PET IMAGING AND RADIOTHERAPY

#6572
20230398236
2023-12-14

Optimized mini-dystrophin genes and expression cassettes and their use

#6573
20230398220
2023-12-14

SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19

#6574
20230398208
2023-12-14

SARS-CoV-2 VACCINES AND USES THEREOF

#6575
20230398200
2023-12-14

MODIFIED CHIKUNGUNYA VIRUSES AND SINDBIS VIRUSES AND USES THEREOF

#6576
20230398189
2023-12-14

Collagen daily with enzyme inhibitors for anti-aging

#6577
20230398157
2023-12-14

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE INTRANASAL SYSTEM

#6578
20230398153
2023-12-14

A METHOD FOR EFFICIENT MICROGLIA REPLACEMENT

#6579
20230398150
2023-12-14

SPECIFIC TARGETING OF TUMOR-INFILTRATING REGULATORY T CELLS (TREGS) USING ICOS AND IL-1R

#6580
20230398141
2023-12-14

THERAPEUTIC CARBON MONOXIDE FORMULATIONS

#6581
20230398139
2023-12-14

Methods and compositions for treating carbapenem-resistant klebsiella pneumoniae infections

#6582
20230398136
2023-12-14

Compositions and methods for treating diseases associated with drug washout due to fluid secretion

#6583
20230398130
2023-12-14

METHODS AND COMPOSITIONS FOR DIFFERENTIATING STEM CELLS

#6584
20230398123
2023-12-14

METHODS TO TREAT INFLAMMATORY BOWEL DISEASE

#6585
20230398122
2023-12-14

Methods of treating B-cell proliferative disorder

#6586
20230398121
2023-12-14

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#6587
20230398101
2023-12-14

Co-agents as Therapy Against Anaerobic Pathogens

#6588
20230398093
2023-12-14

ANTI-METHANOGENIC LOVASTATIN ANALOGS OR DERIVATIVES AND USES THEREOF

#6589
20230398085
2023-12-14

Method of treating cancer using selective estrogen receptor modulators

#6590
20230398077
2023-12-14

SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY

#6591
20230398064
2023-12-14

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA

#6592
20230397598
2023-12-14

Barrier system

#6593
20230392214
2023-12-07

Systems and Methods for Assessing Mutational Burden of Neoplasms And Associated Treatments Thereof

#6594
20230392210
2023-12-07

METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY

#6595
20230392150
2023-12-07

COMPOSITION FOR TREATING RETINAL OR CHOROIDAL DISEASES, CONTAINING ACTA2 INHIBITOR AS ACTIVE INGREDIENT

#6596
20230391875
2023-12-07

DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER

#6597
20230391871
2023-12-07

MONOAMINE OXIDASE BLOCKADE THERAPY FOR TREATING CANCER THROUGH REGULATING TUMOR ASSOCIATED MACROPHAGES (TAMS)

#6598
20230391868
2023-12-07

COMPOSITIONS FOR AND METHODS OF TREATING CANCER

#6599
20230391847
2023-12-07

Methods for treating an ocular condition with cellular fibronectin compositions

#6600
20230391837
2023-12-07

METHODS OF TREATING, AMELIORATING, AND/OR PREVENTING COVID-19 INFECTION AND RELATED INFLAMMATION